Journal of the neurological sciences · 2025
Genetic and clinical profile of a Brazilian cohort of dopa-responsive dystonia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Alencar Guerra Agostinho, Cavalcanti Eduardo Boiteux Uchoa, Montanaro Vinicius Viana Abreu, Hora Thiago Falcao, de Carvalho Daniel Rocha, da Silva Adriana Gonçalves, Ferreira Alessandra De La Rocque, von Glehn Felipe
Аннотация
BACKGROUND: Dopa-responsive dystonia (DRD) is a rare genetic and neurotransmitter disorder also known as Segawa Disease. The guanosine triphosphate cyclohydrolase 1 (GCH1) gene variants, inherited in an autosomal dominant pattern, are the most common cause of DRD.
OBJECTIVES: To describe the genetic and clinical profile of a Brazilian cohort of DRD patients.
METHODS: Twenty-two patients were recruited from the SARAH Network of Rehabilitation Hospitals. A retrospective analysis of phenotype-genotype correlation from the next generation sequencing (NGS) genetic test alongside clinical features and evolution were performed. Clinical measures included: age at the disease onset, gender, time of diagnosis, response to Levodopa medication, behavioral symptoms related to psychiatric disorders.
RESULTS: Variants in genes associated with DRD were detected in 17 patients (77 %), of which 16 (94 %) presented variants in the GCH1 gene (pathogenic variants, n = 10; likely pathogenic variants, n = 6) and, 1 (5 %) in the tyrosine hydroxylase (TH) gene. The average age at disease onset was 7.8 years, with a predominant diagnosis in females, accompanied by a significant delay. A moderate positive response to a low dosage of Levodopa was observed. Patients also reported severe behavioral symptoms related to psychiatric disorders and use of medication.
CONCLUSIONS: The autosomal dominant DYT/PARK-GCH1 was the most prevalent subtype. Not all patients were characterized with typical phenotypes contributing to the significant diagnosis delay. Uncommon occurrences of behavioral symptoms and Levodopa-induced dyskinesias were also found. Particular attention is suggested to the autosomal recessive form of the GCH1.
OBJECTIVES: To describe the genetic and clinical profile of a Brazilian cohort of DRD patients.
METHODS: Twenty-two patients were recruited from the SARAH Network of Rehabilitation Hospitals. A retrospective analysis of phenotype-genotype correlation from the next generation sequencing (NGS) genetic test alongside clinical features and evolution were performed. Clinical measures included: age at the disease onset, gender, time of diagnosis, response to Levodopa medication, behavioral symptoms related to psychiatric disorders.
RESULTS: Variants in genes associated with DRD were detected in 17 patients (77 %), of which 16 (94 %) presented variants in the GCH1 gene (pathogenic variants, n = 10; likely pathogenic variants, n = 6) and, 1 (5 %) in the tyrosine hydroxylase (TH) gene. The average age at disease onset was 7.8 years, with a predominant diagnosis in females, accompanied by a significant delay. A moderate positive response to a low dosage of Levodopa was observed. Patients also reported severe behavioral symptoms related to psychiatric disorders and use of medication.
CONCLUSIONS: The autosomal dominant DYT/PARK-GCH1 was the most prevalent subtype. Not all patients were characterized with typical phenotypes contributing to the significant diagnosis delay. Uncommon occurrences of behavioral symptoms and Levodopa-induced dyskinesias were also found. Particular attention is suggested to the autosomal recessive form of the GCH1.